Expert's Economic Outlook, Global - Equity Research on Teva Pharmaceutical Industries Ltd (ADR) and HollyFrontier Corp
(firmenpresse) - MACAU -- (Marketwire) -- 10/11/11 -- Today, announced its research report highlighting Teva Pharmaceutical Industries Ltd (ADR) (NASDAQ: TEVA) and HollyFrontier Corp (NYSE: HFC). Full content and research is available at .
Short-term outlooks within US and global economies continue to adjust downward, as US Treasury yields touched their lowest levels in over 65 years. International Monetary Fund downgraded estimates for US growth by 1.0% this year, down from 2.5%. 'Significant downside risks' to the US economy were confirmed by the Federal Reserve pressured by 'strains in global financial markets'.
As the US dollar trades above an eight-month high against the Euro, it highlights a deepening of the Eurozone sovereign debt crisis -- furthered by continued policy inaction from European governments. We expect continued volatility until economic data stabilizes and we see decisive policy action to deal with the Eurozone debt crisis.
Our members are preparing for a turn in tides. Currently, the Credit Suisse Risk Appetite Indicator is at a 30-year low. For the past three occurrences, this level has acted as a leading indicator of large stock market rallies 18 months following.
Equity Markets has reviewed Teva Pharmaceutical Industries Ltd (ADR) for its current position within the healthcare industry. Teva Pharmaceutical Industries Limited (Teva) is a global pharmaceutical and drug company. It develops, produces and markets generic drugs in all treatment categories. The Company has a pharmaceutical business, whose principal products include Copaxone and Azilect. The full research report on Teva Pharmaceutical Industries Ltd (ADR) (NASDAQ: TEVA) is available here: .
Equity Markets has reviewed HollyFrontier Corp for its development within the basic materials industry. HollyFrontier Corporation, formerly Holly Corporation, is an independent petroleum refiner that produces light products, such as gasoline, diesel fuel, jet fuel, specialty lubricant products, and specialty and modified asphalt. It has two segments: Refining and Holly Energy Partners, L.P. (HEP). The full research report on HollyFrontier Corp (NYSE: HFC) is available here: .
About Equity Markets
Our mission at Equity Markets is to be the best source of content and research, while educating, enlightening and informing investors. Equity Markets combines street smart analysts and professional market researchers to provide investors with detailed company profiles and market coverage.
Contact:
Samuel Littman
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 11.10.2011 - 07:00 Uhr
Sprache: Deutsch
News-ID 1044417
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
MACAU
Phone:
Kategorie:
Commercial & Investment Banking
Anmerkungen:
Diese Pressemitteilung wurde bisher 66 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Expert's Economic Outlook, Global - Equity Research on Teva Pharmaceutical Industries Ltd (ADR) and HollyFrontier Corp
"
steht unter der journalistisch-redaktionellen Verantwortung von
Equity Markets Inc (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
